Male breast cancer (MBC) is rare and largely hormonally driven. Here, the authors examine the action of steroid hormone receptors in male and female breast cancers and find gender selective hormone receptor action that associates with the survival of MBC patients
: Here, we report that in T47D breast cancer cells 50 pM progestin is sufficient to activate cell cy...
Male breast cancer (MBC) is extremely rare and accounts for less than 1% of all breast malignancies....
The incidence of many types of cancer arising in organs with non-reproductive functions is significa...
Male breast cancer (MBC) is rare and largely hormonally driven. Here, the authors examine the action...
The cellular response to circulating sex steroids is more than the sum of individual hormone actions...
Male breast cancer remains understudied despite evidence of rising incidence. Using a co-ordinated m...
Abstract Background Male breast cancer (MBC) is rare, accounting for only around 1% of all breast ca...
Background: Estrogen receptors alpha (ERa) and beta (ERb) are transcription factors (TFs) that media...
Upon activation by estrogen, the Estrogen Receptor binds the chromatin and influ...
Background: Estrogen receptors alpha (ERa) and beta (ERb) are transcription factors (TFs) that media...
Breast cancer (BrCa) is the most common cancer in the UK. The majority of BrCa cases are oestrogen r...
Estrogens are tumor promoters for the mammary gland, due to their ability to control multiple functi...
Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and assessed clinicopa...
Summary: The cancer research field is finally starting to unravel the mystery behind why males have ...
: Here, we report that in T47D breast cancer cells 50 pM progestin is sufficient to activate cell cy...
Male breast cancer (MBC) is extremely rare and accounts for less than 1% of all breast malignancies....
The incidence of many types of cancer arising in organs with non-reproductive functions is significa...
Male breast cancer (MBC) is rare and largely hormonally driven. Here, the authors examine the action...
The cellular response to circulating sex steroids is more than the sum of individual hormone actions...
Male breast cancer remains understudied despite evidence of rising incidence. Using a co-ordinated m...
Abstract Background Male breast cancer (MBC) is rare, accounting for only around 1% of all breast ca...
Background: Estrogen receptors alpha (ERa) and beta (ERb) are transcription factors (TFs) that media...
Upon activation by estrogen, the Estrogen Receptor binds the chromatin and influ...
Background: Estrogen receptors alpha (ERa) and beta (ERb) are transcription factors (TFs) that media...
Breast cancer (BrCa) is the most common cancer in the UK. The majority of BrCa cases are oestrogen r...
Estrogens are tumor promoters for the mammary gland, due to their ability to control multiple functi...
Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and assessed clinicopa...
Summary: The cancer research field is finally starting to unravel the mystery behind why males have ...
: Here, we report that in T47D breast cancer cells 50 pM progestin is sufficient to activate cell cy...
Male breast cancer (MBC) is extremely rare and accounts for less than 1% of all breast malignancies....
The incidence of many types of cancer arising in organs with non-reproductive functions is significa...